Often drawing support from its investigations, litigation, and regulatory teams, A&O Shearman houses a broad offering known for its strength in SPC disputes within the pharma industry and strategic M&A. The group also has broad expertise spanning post-M&A cases, divestments, and patent infringement actions. Laëtitia Bénard leads the team and is recommended for her vast experience in multi-jurisdictional patent disputes within the life sciences sector, often representing pharma companies. Charles Tuffreau is well equipped to handle preliminary injunction proceedings and cases concerning patent infringement and validity.

Jointly headed by Armand Aviges and Jean-Nicolas Soret, the practice at ADVANT Altana often advises clients on seed capital fundraisings and cases involving allegations of anti-competitive behaviour. Aviges is known for his standout expertise in pharma product liability, acting for pharma companies in collective actions. Soret is an expert in joint ventures, and both public and private M&A, particularly within the medtech and biotech industries. Gilles Gaillard assists a varied client base of investors and funds, in addition to start-ups, while Delphine Lapillonne is a key name for healthcare class actions and occupational illness claims.

Dechert LLP houses a broad team known for handling the full spectrum of mandates within the sector, including IPOs, health product marketing disputes, and public private partnership (PPP) issues. Practice co-lead Mélanie Thill-Tayara is a key contact for pharma clients seeking advice on cartel and abuse of dominance proceedings on a domestic and EU level. Co-head Alain Decombe is recommended for his longstanding corporate knowledge, advising on joint ventures and asset deals. ‘Brilliant’ regulatory expert Sophie Pelé often appears before administrative courts and entities on behalf of key players within the life sciences sector. Marion Provost is noted for her ability to advise on the antitrust aspects of M&A and merger filings, in addition to handling cartel investigations.

Praised by clients for its ‘perfect knowledge’, Dentons is noted for handling the full gamut of mandates across the life sciences and healthcare sectors. All jointly leading the group, Jean-Marc Grosperrin‘s primary areas of expertise are private equity transactions and cross-border M&A within the pharmacy and biotech industries; Anne-Laure Marcerou is well versed in complex transactions, namely divestitures and strategic contractual matters; and Julien Le Guyader is recommended for his vast knowledge of market access and reorganisations within the medtech and pharma industries. Loïc Lemercier is a seasoned patent litigator who routinely acts in patent infringement and unfair competition cases, while Jessica Garestier stands out due to her regulatory specialism.

The team at Hogan Lovells (Paris) LLP is noted by clients for its ‘exceptional quality’, handling product liability claims, patent disputes, and preliminary injunctions. The group is also adept at advising on clinical trial issues, often acting in mandates with cross-jurisdictional elements. Mikael Salmela leads the team with his standout knowledge of M&A, supply issues, and data processing authorisations within the life sciences sector. The ‘exceptional’ Charlotte Damiano is a regulatory expert noted for handling market access matters, with a strong focus on pricing and reimbursement work. Damiano often acts in cases concerning pharma product financial regulation.

HOYNG ROKH MONÉGIER maintains its strong reputation for IP litigation and SPC-related issues, in addition to pricing and reimbursement matters. Team co-head Anne Servoir stands out due to her longstanding experience in competition matters within the pharma and biotech industries, often assisting originator companies with supply chain management and reimbursement issues. Experienced patent litigator Benoît Strowel works between the Paris and Brussels offices, often acting in multi-jurisdictional patent disputes. Sabine Agé has longstanding expertise in parallel overseas litigations, particularly in relation to pharma, biotech, and medical devices.

Led by Emmanuelle Trombe, the team at McDermott Will & Emery AARPI often utilises its ‘great responsiveness and remarkable listening skills’ to assist major clients across the cosmetics, pharma, and food industries. Trombe is known for her vast transactional expertise, often advising on M&A, joint ventures, and strategic partnerships across the pharma, healthcare, and medical device sectors. Anthony Paronneau is a key name for venture capital and private equity firms, particularly in relation to private acquisitions, while Anne-France Moreau is noted for her expertise in licensing transactions and investments.

The practice at Simmons & Simmons is known for handling major product liability claims, often appearing before criminal, civil, and administrative courts. Alexandre Regniault leads the team alongside Jacques-Antoine Robert; Regniault is an expert in clinical trial agreements, in addition to product liability and unfair competition claims, while Robert is known for his specialism in class actions concerning pharma products. Ombline Ancelin is well known for her broad knowledge of distribution issues, and investigations by competition authorities. Simonetta Giordano often assists with joint ventures, M&A, and commercial contractual issues, and Abdelaziz Khatab joined the team in May 2024 from August Debouzy.

August Debouzy‘s offering exhibits ‘unparalleled’ experience in the full spectrum of life sciences IP issues and the data protection aspects of clinical trials, particularly relating to personal data transfers. The team is also well equipped to handle unfair competition work. Team co-lead François Pochart is noted for his broad knowledge of regulations governing medical devices and medicinal products, in addition to his strong focus on global pharma disputes. Co-lead Grégoire Desrousseaux utilises his ‘very significant’ experience in life sciences patent issues to assist clients with infringement actions and seizures, while practice co-head and qualified patent attorney Lionel Martin often acts in opposition proceedings before the EPO and the UPC.

Baker McKenzie houses a ‘dedicated and committed’ team known for its broad experience spanning strategic collaborations, pricing and reimbursement work, and French transparency mandates. The group acts for a diverse and high-profile client base of global pharma and biotech corporates. The ‘excellent’ Julie Yeni heads the practice, utilising her vast knowledge of clinical trials and market access issues, with a strong focus on personal data processing. Yeni is also adept at advising on distribution and supply issues. Melodie Truong is another key figure within the team.

Emmanuelle Porte and Anne-Charlotte Le Bihan jointly lead the team at Bird & Bird, which stands out due to its strong focus on both contentious and non-contentious IP work within the medtech and pharma industries, in addition to its strong capabilities in handling tender offers. The team is particularly adept at advising venture capital funds and innovation-focused companies on their fundraising activities. Porte regularly advises on venture capital issues and M&A, assisting medtech, healthcare, and biotech clients, and Le Bihan is well known for her strength in patent litigation within the pharma industry, often coordinating pan-European litigation. Ariane Mole is an expert in data protection, often appearing before the French Data Protection Authority. Alexandre Vuchot often assists with commercial contractual issues, namely distribution and procurement arrangements, while Johanna Harelimana is noted for her broad regulatory experience, particularly in relation to market access and product qualification issues.

The Clifford Chance team is well equipped to handle the full range of antitrust issues, including EU antitrust investigations involving allegations of abuse of dominant position and misuses of IP. The group is also noted for its strong employment disputes capabilities, in addition to its handling of governance-related matters. Marianne Pezant is a key contact for private equity firms and major corporations seeking advice on M&A within the life sciences and healthcare space, while David Tayar is recommended for his vast knowledge of abuse of dominance and restrictive arrangement cases, in addition to state aid investigations. Dominique Laymand often assists with compliance issues.

De Gaulle Fleurance & Associés‘ team is known for handling the full gamut of matters relating to the manufacturing, supply, and distribution of health products, and service agreements. The team is also noted for its specialism in cannabis products and digital health. Practice co-head Jean-Marie Job is an expert in personal and commercial data management, and in market access issues concerning biotech and pharma products. The ‘outstanding’ Cécile Théard-Jallu co-leads the team alongside Job, and stands out due to her strong focus on matters involving sensitive data and artificial intelligence, combined with healthcare and life sciences regulation, often advising on clinical research projects and licensing mandates. Co-head Francine Le Péchon-Joubert has vast experience in assisting with trade mark filings and prosecutions on both a domestic and EU level, while Kevin Ishac is well versed in the full range of IP and data protection issues within the healthcare and life sciences sector.

Delsol Avocats stands out due to its specialism in health data issues, including data warehouses and matters involving artificial intelligence. The group is also well equipped to handle healthcare asset acquisitions, in addition to advising on the regulations surrounding early access to medicines and e-health. Jeanne Bossi Malafosse is an expert in the full spectrum of issues relating to health information systems, particularly in relation to medical research and the sharing of health data within the medicosocial and healthcare industries. ‘Excellent technician’ Gaëlle Merlier‘s workload consists of compliance matters, M&A, and product liability claims concerning health products.

DLA Piper houses a ‘very cohesive and diligent’ practice known for its strength in carve-outs of businesses within the medical device industry, issues surrounding the financing of healthcare providers by private equity funds, and M&A. Sonia De Kondserovsky leads the group, utilising her vast experience to advise on R&D and clinical trials agreements, strategic collaborations, and acquisitions of manufacturing sites. Denise Lebeau-Marianna is an expert in data protection and processing, often advising international pharma and biotech clients. Frank Valentin has longstanding experience in patent litigation and trade mark issues, often advising North American clients, while Marion Abecassis has expansive expertise in the domestic and EU rules governing clinical trials, advertising, and the relationships between healthcare professionals and industry players.

Fieldfisher‘s broad offering is noted for its strong focus on digital health work and contentious reimbursement matters. Olivier Lantrès leads the team, utilising his ‘perfect’ industry knowledge to handle the full gamut of regulatory issues surrounding medical devices, cosmetics, and pharma products. Described by clients as ‘one of the best lawyers in health and digital law in France’, Marguerite Brac de la Perrière is a key contact for medtech, biotech, and start-up clients seeking advice on software contracts and issues surrounding data warehouses. Nathalie Hadjadj-Cazier is an expert in both contentious and non-contentious IP work, including the drafting of licensing agreements and trade mark litigation.

Gide Loyrette Nouel A.A.R.P.I. houses an ‘efficient, experienced, dedicated’ team which handles a broad range of health data, patent infringement, and financing matters. Raphaëlle Dequiré-Portier is a key name for patent validity and infringement cases, in addition to SPC issues; Jean-Hyacinthe de Mitry has longstanding experience in unfair competition and trade secret protection work; and Emmanuel Larere is a seasoned patent litigator who often represents cosmetics clients in trade mark mandates. Arnaud Duhamel routinely advises investors and issuers on equity derivatives transactions, and capital markets expert Melinda Stege Arsouze has a strong focus on emerging markets, while Thierry Dor is knowledgeable about personal data law and AI projects. Dimitri Dimitrov is well equipped to handle merger notifications and distribution issues, while Anne Tolila often advises on M&A and divestment projects.

Praised for its ‘remarkable knowledge’ of the biotech industry, HBC Avocats acts for a diverse client roster of life sciences-focused venture capital firms, biotech corporates, and clients active within the agricultural biotech space. Practice co-lead Jonathan Burnham is well known for his expansive knowledge of global licensing and collaboration agreements, and sublicence agreements. Co-head Erwan Cossé has broad experience in the full range of corporate matters within the health care and life sciences sector, often advising on investment agreements.

Diane Bandon-Tourret, Alain de Belenet, and Raphaël Apelbaum all jointly lead the group at LexCase, which is known for its ‘well-founded expertise and professionalism’. The group is well equipped to advise on collective claims relating to medical devices, and marketing authorisation issues. Bandon-Tourret regularly assists medical device manufacturers and pharma companies with product liability matters, while de Belenet stands out due to his knowledge spanning the full range of public law issues concerning healthcare products. Apelbaum is an expert in contractual penalties and local public health agency inspections, while Clémentine Calvet focuses on the data protection aspects of healthcare, including e-health projects.

Norton Rose Fulbright is recommended for its vast knowledge of competition issues within the life sciences sector, and personal data mandates concerning early access and clinical trials. Practice co-lead Marta Giner Asins is known for her expansive expertise in antitrust and competition issues within the life sciences and healthcare sector, while co-lead Karine Montagut specialises in M&A and investment issues. Christian Dargham is an expert in all matters concerning compliance, particularly investigations and compliance programmes, while Nadège Martin often assists with early access authorisations and licensing transactions.

Reed Smith houses a broad practice known for advising major pharma, cosmetics, and investor clients. All jointly leading the team, Daniel Kadar is a key name for healthcare compliance and risk assessment mandates, Marc Lévy is experienced in handling follow-on damages claims and abuse of market power cases, and Natasha Tardif is an expert in distribution issues and anti-competitive practice-related claims. Lucile Chneiweiss often advises on investigations and merger control proceedings.

Boutique firm Viguié Schmidt & Associés is recommended for its strength in administrative disputes, financing issues, and the full range of antitrust and competition issues within the sector. Etienne Gouesse is noted for his vast regulatory knowledge and his ability to handle major disputes, particularly product liability claims and cases concerning market authorisations, while Iñaki Saint-Esteben stands out due to his vast experience in merger control and antitrust issues within the life sciences and healthcare sector.

Noted for its strong focus on the healthcare industry, Winston & Strawn LLP‘s ‘innovative and creative’ team is well placed to assist with acquisitions and financing work. Gilles Bigot assists a varied client list consisting of pharma product and medical equipment manufacturers, private health institutions and professional associations. Private equity and M&A specialist Julie Vern Cesano-Gouffrant is a key port of call for investors and healthcare professionals seeking advice on the full range of transactional issues within the healthcare and life sciences sector.

BCTG Avocats acts for a diverse client list which notably includes Teva Santé and Servier. Hugues Villey-Desmeserets regularly advises clients on commercial policy issues, in addition to competition and regulatory matters, areas in which François Dauba is also an expert. Gaëlle Bloret-Pucci has longstanding experience in IP litigation, often appearing before the Paris Commercial Court and Civil Court. Séverin Kullmann leads the firm’s M&A and private equity group, and assists clients with joint ventures and reorganisations.

Goodwin houses a broad offering known for its strength in financing mandates, patent infringement actions, and co-development and distribution agreements. Anne-Charlotte Rivière heads the practice, and is recognised for her vast expertise in venture capital, private equity, and M&A work within the life sciences space, particularly in relation to fundraisings. Rivière assists both global and domestic life sciences venture funds. Marie Fillon leads the firm’s IP group, with her primary area of expertise being collaboration, R&D, and manufacturing agreements.

Often collaborating with its expansive international network, Herbert Smith Freehills LLP‘s team stands out for its handling of patent revocation and enforcement actions, in addition to issues surrounding patent validity. Frédéric Chevallier is recommended for his strong focus on patent litigation and regulatory issues within the pharma industry, often representing global pharma corporations.

Praised by clients for its ‘excellent’ knowledge, jasper Avocats stands out due to its product liability and clinical injury expertise. The group often assists healthcare professional associations and healthcare providers. Co-heading the practice, Olivier Saumon is well versed in the rules governing the sale of medicinal products online and criminal proceedings within the healthcare sector, and Céline Roquelle-Meyer is recommended for her longstanding experience in advising professional associations on professional practice contracts and governance structure. Jean-François Laigneau regularly handles transactional and regulatory issues concerning medical devices, cosmetics, and food supplements.

Françoise Labrousse and Renaud Bonnet co-lead the team at Jones Day, which often advises on collaboration and investment agreements. Labrousse is recommended for her deep knowledge of administrative disputes, while private equity specialist Bonnet often assists with M&A, IPOs, and the full spectrum of financing issues. Described by clients as ‘one of the foremost patent litigators in France’, Thomas Bouvet is well equipped to advise on SPCs, standard essential patents, and patent enforcement actions relating to medical devices and pharma products.

Praised by clients for its ‘exceptional precision’, Latham & Watkins often handles M&A and series financing mandates, acting for medical equipment companies, investors, and medical device clients. The ‘outstanding’ Eveline Van Keymeulen leads the team and is recommended for her vast experience in EU regulatory issues, particularly in relation to medical cannabis and hemp-based products. Jeanne Fabre regularly assists clients with market access strategy, advertising compliance, and clinical trial-related matters.

The offering at Magenta is recommended for its strong focus on regulatory issues, particularly in relation to pricing and reimbursement, and financing within the pharma and medical device industries. Practice head Gaël Hichri‘s primary areas of expertise are competition and distribution, often appearing before the French Competition Authority in abuse of dominant position cases. Hichri is also noted for his knowledge of supplier and distributor disputes. Benjamin Jothy is another key figure within the team.

Mercure Avocats houses an ‘expert, dynamic and responsive’ team known for handling R&D and EU distribution agreements, in addition to work relating to the remote provision of health services and financing mandates. Agathe Simon specialises in M&A and corporate issues, particularly shareholder and joint venture agreements within the healthcare sector. François-Maxime Philizot stands out due to his regulatory knowledge, often in relation to pharma and medical device products.

Described by clients as being ‘at the forefront of European patent litigation’, the team at Pinsent Masons LLP routinely appears before the UPC in infringement proceedings. Jules Fabre is a key contact for multi-jurisdictional patent and SPC disputes, while Annabelle Richard focuses on GDPR-related issues and tech transactions. Camille Chiari is well versed in M&A and joint ventures, and Melina Wolman stands out due to her product liability expertise.

Taylor Wessing regularly advises clients on market access issues, the opening of new enterprises in the pharma industry, and manufacturing agreements. Evelyne Friedel leads the team, and specialises in both competition and commercial issues within the life sciences and healthcare sector. Marc Schuler has longstanding experience in IT and IP law, particularly in relation to data management. Annabelle Lebaudy is well equipped to assist with R&D, licence, and supply agreements, while Marine Boullenger regularly assists clients with compliance programmes.

Bignon Lebray houses a broad offering known for handling unfair competition cases and data protection matters. In Lyon, Barbara Bertholet leads the team with her longstanding experience assisting a diverse client list of medical device and cosmetic manufacturers, and laboratories. Paris’ Caroline Cazaux often draws on her broad antitrust and competition expertise to advise on distribution issues surrounding healthcare and food products.

Ginestié Magellan Paley-Vincent regularly assists both public and private healthcare establishments and investors with practice contracts and professional ethics issues. Nathalie Boudet-Gizardin heads the practice, and is recommended for her deep experience in assisting healthcare professionals with criminal proceedings and partnerships with health entities. Fabienne Kerebel and Camille Faour are other key figures within the team, with Kerebel standing out for her vast knowledge of M&A and corporate governance issues.

Led by Christophe Hénin, the team at Intuity is well equipped to assist with product liability claims and reimbursement issues, in addition market authorisation negotiations. Hailed by clients for ‘his experience and knowledge of the pharmaceutical field’, Hénin is particularly adept at handling distribution, product liability, and data protection issues, while Alain Gorny has vast experience in pharma advertising disputes.

LERINS is known for its specialism in M&A, healthcare real estate, and takeovers of public and private healthcare establishments. Practice head Luc Castagnet is particularly adept at assisting investment funds and private healthcare entities with M&A and public-private partnership-related issues. Bertrand Vorms is well equipped to handle practice contracts, often representing healthcare manufacturers and healthcare coordination groups, while public health expert Bruno Lorit often advises on pricing disputes and issues arising as a result of collaboration between healthcare entities.

MCE CARREL is particularly active across the biotech industry, often assisting with investment and commercialisation issues. Alexandra Carrel is noted for her vast knowledge of mandates concerning the manufacturing, production, and distribution of healthcare products, and the negotiation of licence and collaboration agreements. Drawing on her prior expertise within the pharma industry, Mathilde Salavin often advises on clinical trial agreements and commercial partnerships.

The broad and ‘extremely competent’ offering at Osborne Clarke often assists clients which are active within the medtech and pharma industries, particularly in relation to rare diseases. Thomas Devred leads the team, and is well equipped to advise on licensing, market access, and supply chain issues, in addition to handling data privacy issues involving patient data. Regulatory expert Léa Masson-Boukobza often acts for medical device and pharma clients in matters involving anti-gift rules, advertising, and clinical trials.

Product Law Firm is active across the medical device and healthcare industries. Paul-Henry Devèze leads the team with his strong knowledge of R&D, marketing, and distribution mandates, in addition to acting in criminal medical law cases concerning the liability of healthcare professionals and providers. Antoine De Brosses is noted for his specialism in food law.

Jointly led by Carole Sportes and Valérie Ravit, the team at Squire Patton Boggs is recommended for its specialism in administrative and commercial proceedings and investigations, and is praised by clients for its ‘exceptional mastery’ of product liability law. The team is also well equipped to assist with investment matters. In addition to heading the firm’s international disputes group, Sportes is a key name for product liability claims, an area in which Ravit is also an expert.

Regularly representing pharma companies in SPC appeals, the team at Taliens is also adept at handling trade secret litigation. Grégoire Triet is noted for his expertise in SPC cases, while Jean-Frédéric Gaultier stands out due to his deep knowledge of unfair competition and IP litigation.

UGGC Avocats houses a ‘close-knit and technically advanced’ team which acts for both domestic and global pharma companies and venture capital firms. Practice co-head Sylvie Welsch is an expert in mass litigation concerning medical liability and mandates involving the promotion of health products. ‘Highly skilled professional’ Malka Marcinkowski co-leads the team and is noted for assisting clients with issues concerning CE marking and product distribution, while Alison Leroy is a key contact for real estate projects within the pharma industry, often assisting healthcare institutions.